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ÖZET
Amaç: Liken planus T lenfositlerin bazal hücreleri hedef 
aldığı lenfosit aracılı immünolojik bir hastalıktır. T lenfo-
sitlerinden ve keratinositlerden salınan TNF-α’nın apop-
tozisi indükleyerek liken planusun başlangıç ve progres-
yonunda  anahtar  rolü  oynadığı  düşünülmektedir.  Bazal 
keratinositlerin  üzerindeki  MHC  Class-I  antijenler  ve 
CD4+ T hücrelerinden üretilen IL-2 ve IFN-gamma (γ) li-
ken planusta keratinositlerin apoptozisini tetiklemektedir. 
Bizim çalışmamızın amacı liken planuslu hastaların peri-
ferik kanlarındaki İL-2 ve TNF-α seviyelerini saptamaktır.
Gereç ve yöntem: Dicle Üniversitesi Tıp Fakültesi Der-
matoloji polikliniğine 2004-2006 yılları arasında başvuran 
26 liken planuslu hasta (18 kadın, 8 erkek) ve sağlıklı kon-
trol grubu çalışmaya alındı. Serum IL-2 ve TNF-α seviye-
leri Immulate 1000 solid faz ve two-site chemiluminescent 
immunometric assay yöntemi kullanılarak ölçüldü. Hasta 
ve kontrol grubunun sonuçları istatistiksel olarak karşılaş-
tırıldı.
Bulgular: IL-2 (1172,615 ± 774,967) ve TNF-α (13.361 
±  5,638)  seviyeleri  liken  planuslu  hastalarda  kontrolle-
re göre daha yüksek saptandı. Hasta grubunda IL-2 ve 
TNF-α seviyeleri, sağlıklı kontrollere göre istatistiksel ola-
rak anlamlı derecede yüksek bulundu (sırasıyla p=0.004 
ve p<0.001).
Sonuç: Liken planuslu hastalarda yüksek olarak bulunan 
IL-2 ve TNF-α seviyeleri hastalığın patogenezinde immü-
nitenin rolünü desteklemektedir.
Anahtar kelimeler: Liken planus, IL-2, TNF-α
ABSTRACT
Objectives:  Lichen  planus  is  an  immunologic  disease 
mediated by lymphocytes in which T lymphocytes target 
at basal cells. It is believed that TNF-α that is released 
from T lymphocytes and keratinocytes plays a key role in 
the starting and progression of lichen planus by inducing 
apoptosis. MHC Class-I antigens on basal keratinocytes 
and interleukin-2 (IL-2) and IFN-gamma (γ) that are pro-
duced from CD4+ T cells stimulate the apoptosis of ke-
ratinocytes in lichen planus. The aim of this study was to 
measured the IL-2 and TNF-α levels in peripheral blood 
from patients with Lichen planus.
Materials and methods: A total of 26 lichen planus pa-
tients (18 females, 8 males) that applied to the dermatol-
ogy policlinics in Dicle University Hosspital between 2004 
and 2006 and a healthy control group were included in 
the study. Serum IL-2 and TNF-α levels were measured 
by using Immulate 1000 solid phase and two-site chemi-
luminescent immunometric assay method. The results of 
patients and control group were compared.
Results: Level of IL-2 (1172.615 ± 774.967) and TNF-α 
(13.361 ± 5.638) were higher in lichen planus to compared 
controls. IL-2 and TNF-α levels in the patient group were 
found  to  be  significantly  high  statistically  compared  to 
health control group, respectively p=0.004 and p<0.001. 
Conclusion: The high levels of IL-2 and TNF-α in lichen 
planus patients support the role of immunity in the patho-
genesis of the disease.
Key words: Lichen planus, IL-2, TNF-αD. Uçmak et al. IL-2 and TNF-α in lichen planus 7
Dicle Tıp Derg / Dicle Med J    www.diclemedj.org   Cilt / Vol 39, No 1, 6-8
INTRODUCTION
Lichen planus is a chronic inflammatory disease in 
which skin and mucous membranes are affected. It 
plays an important role in the immunological reac-
tion pathogenesis mediated by the cell stimulated 
by the antigenic changes in skin and mucous, how-
ever its etiology is not yet known exactly1. The ma-
jor intraepithelial lymphocytes in lichen planus are 
CD8+ cytotoxic T lymphocytes. TNF-α that is re-
leased by these cells and that is found at high levels 
of serum in active disease plays an important role 
in apoptosis pathogenesis.1,2 In the lesions of lichen 
planus, subepithelial CD4+ helper T cells were de-
tected in the ratio of 20-40%. The role of T helper1 
cells couldn’t be explained completely in the patho-
genesis. However, the physiological response to an-
tigen or dysregulation of the immune response may 
be stimulating the TH1 activity. It is considered that 
these subepithelial T cells release pro-inflammatory 
cytokines such as IFN- γ and IL-2 and play role in 
the pathogenesis of the disease.2 Based on this in-
formation, we tried to demonstrate the role of im-
munity in the disease by detecting the serum levels 
of IL-2 and TNF-α.
MATERIALS AND METHODS
A total of 26 lichen planus patients (18 females, 8 
males) that applied to the dermatology policlinic of 
Faculty of Medicine of Dicle University between 
2004 and 2006 and a healthy control group were in-
cluded in the study. The patients that had used topi-
cal and systemic medicines 3 months prior to the 
study and the pregnant women and active hepatitis 
patients were not included in the study. All of the 
patients were inquired in respect of the age, gender, 
duration of disease and clinical type of the disease. 
26 healthy volunteers were included in the study as 
control group. Serum IL-2 and TNF-α levels were 
measured by using Immulate 1000 solid phase and 
two-site  chemiluminescent  immunometric  assay 
method. Results were statistically evaluated by stu-
dent t test.
RESULTS
The ages of patients varied between 17 and 70 (av-
erage 43,65) years while they varied between 20 
and 70 (average 46.80) in the control group. Statis-
tically, the age distribution with the control group 
was found to be homogenous. The duration of dis-
ease varied between 2 months and 3 years. Serum 
TNF-α levels in patients were found to be high in 
17 of 26 patients while levels of IL-2 were high in 
13 of 26 patients (Table 1). When these results are 
compared with the control group, they were found 
to be significant (p<0.001).
Tablo 1.  Statistical  comparison  of  patient  and  control 
groups
Group n Average P
Gender 1 26 0.692±0.470 0.265
2 26 0.615 ± 0.496
Age 1 26 43.65±3.40 0.132
2 26 48.3±10.0
Duration 1 26 10.0± 14.1 0.001
2 26 0.00 ± 0.00
Type 1 26 1.95 ± 1.26 <0.001
2 26 0.00 ± 0.00
TNF-α 1 26 13.36 ± 5.64 <0.001
2 26 7.66 ± 1.65
IL-2 1 26 1172 ± 775 0.004
2 26 645 ± 184
DISCUSSION
Lichen planus is a T cell mediated inflammatory 
dermatosis.3  Degeneration  is  observed  in  histo-
pathologically  common  subepidermal  cell  infil-
trates, numerically increased intraepithelial T cells 
and  basal  cells.  Degenerated  basal  keratinocytes 
form  eosinophilic  globules  containing  colloid  or 
Civatte  bodys.4,5  The  recent  studies  suggest  that 
auto-reactive T cells stimulate keratinocytes apop-
tosis in lichen planus.6 Cell mediated immunity in 
lichen planus is regulated by many cytokines and 
receptors. In a study conducted by Khan et al.; the 
cytokines that are released from lesion T cells were 
examined in vitro and both pro-inflammatory (INF- 
γ IL-2, TNF-α) and immunosuppressive (TGF-beta) 
cytokines were detected. It was concluded that these 
cytokines may be effective in the clinical progress 
of the disease.2
In lichen planus lesions, subepithelial and in-
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T cells. In previous studies, CD8+T lymphocytes 
were detected in adjacent areas to degenerated basal 
keratinocytes too.7,8 In addition, it was detected that 
CD8+ T cell clones isolated in lichen planus lesions 
showed cytotoxic activity against autologous kerati-
nocytes in vitro.6,9 All this information suggests that 
CD8+ cytotoxic T cells play important role in the 
pathogenesis of the disease and stimulate keratino-
cytes apoptosis.2
Apoptosis is a systematical dying of cells.4,10 
Apoptotic mechanism is responsible for the basal 
cell degeneration in lichen planus.5 Regulation of 
apoptosis is relate to the relationship between effec-
tor and suppressor molecules.11 The probable mech-
anisms that T cells stimulate keratinocytes apoptosis 
might be: (i) linking of TNF-α that is release from T 
cells to the TNF-α receptor-1 (TNF R1) on the sur-
face of the keratinocyte; (ii) linkage of Fas receptor 
(FasR) on the T cell surface to Fas ligand (FasL); 
or (iii) granzyme B that is released from T cells and 
cause perforations in membrane pores.9 In previous 
studies, serum TNF-α levels were found to be high 
in lichen planus patients and it was demonstrated 
that lesional T cells contained TNF-α m-RNA and 
released TNF-α in vitro.3,12 Based on this informa-
tion, although it is considered that CD8+ cytotoxic 
T cells release TNF-α and stimulated keratinocyte 
apoptosis by means of TNF R1, the role of Fas and 
granzyme B in the pathogenesis could not be ex-
cluded.2
In latest studies, CD4+ helper T cells were de-
tected in the ratio of 20-40% especially in lamina 
propiada in the subepidermal infiltrate in lichen pla-
nus.13 In early lichen planus lesions, CD4+ helper T 
cells are activated as a result that antigen is linked 
to MHC class II in lichen planus lesions. This is fol-
lowed by the activation of CD8+ cytotoxic T cells 
that stimulate keratinocytes apoptosis. Presentation 
of MHC Class II antigen in lichen planus may be 
provided by Langerhans cells and keratinocytes.14 
In lesional skin, MHC class II upregulation and in-
crease in langerhans cells were detected. It stimu-
lates a high level of antigen expression, CD40 and 
CD80 coexpression and IL-12 secretion from cells 
presenting  antigen  and  IL-2  and  INF-γ  secretion 
from Th1 CD4+T cells.15 Subsequently, CD8+ cy-
totoxic T cells are activated by both antigens related 
to MHC class I in basal keratinocytes and also by 
IL-2  and  INF-γ  that  are  generated  from  CD4+T 
cells.  In  conclusion,  activated  CD8+  cytotoxic T 
cells stimulate apoptosis in basal keratinocytes in 
lichen planus.2
In our study, IL-2 and TNF-α levels in the pa-
tient group were found to be significantly high sta-
tistically compared to health control group. The high 
levels of IL-2 and TNF-α in lichen planus patients 
support the role of immunity in the pathogenesis of 
the disease.
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